SCHEMBL14217025

SCHEMBL14217025

N[C@H](Cc1c[nH]c2ccccc12)OC=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.59
HTR1D P28221 2/20 0.59
HTR1B P28222 2/20 0.59
HTR2C P28335 2/20 0.59
HTR7 P34969 2/20 0.59
HTR6 P50406 2/20 0.59
ADRB1 P08588 1/20 0.59
HTR1A P08908 1/20 0.59
ADRA2A P08913 1/20 0.59
SLC6A2 P23975 1/20 0.59
HTR1E P28566 1/20 0.59
SLC6A4 P31645 1/20 0.59
HTR2B P41595 1/20 0.59
SLC6A3 Q01959 1/20 0.59
MAPT P10636 3/20 0.57
KDM4E B2RXH2 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
MPO P05164 2/20 0.57
PMP22 Q01453 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14217034 1.00 HTR2A (0.59) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL28229177 0.82 HTR2A (0.51) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL120494 0.81 MAPT (0.67) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL28548119 0.81 MAPT (0.67) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL2198661 0.80 HTR2A (0.64) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL10650990 0.80 HTR2A (0.64) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL7029247 0.80 HTR2A (0.64) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL14217026 0.80 HTR2A (0.61) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL15639162 0.80 HTR2A (0.61) HTR2AHTR1DHTR1BHTR2CHTR7
SCHEMBL14217032 0.80 HTR2A (0.61) HTR2AHTR1DHTR1BHTR2CHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169247-B2 Tetrahydro-beta-carboline derivatives, synthesis and use thereof SOUTHERN RESEARCH INSTITUTE (US) 2015-10-27 US disclosed
US-20120309781-A1 TETRAHYDRO-beta-CARBOLINE DERIVATIVES, SYNTHESIS AND USE THEREOF SOUTHERN RESEARCH INSTITUTE (US) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309781-A1 TETRAHYDRO-beta-CARBOLINE DERIVATIVES, SYNTHESIS AND USE THEREOF PDE5A, PDE3A, PDE3B HTR2A 799/4885HTR1D 1262/4885HTR1B 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.